Linagliptin, metformin HCl ext-rel; 2.5mg/1000mg, 5mg/1000mg; tabs. Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose ...

The Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin, metformin HCl extended-release; Boehringer Ingelheim and Lilly) tablets as adjunct to diet and exercise to improve ...

Products covered by the Royalty Agreement and amendment include Glumetza ® and its authorized generic, Jentadueto XR ®, Invokamet XR ® and Synjardy XR ®. About PDL BioPharma PDL seeks to ...

Products covered by the royalty agreement and amendment include Glumetza and its authorized generic Jentadueto XR as well as Invokamet XR and Synjardy XR. Following the amendment, PDL will now ...